Clinical management of beta-thalassemia.
D000293:Adolescent; D000328:Adult; D001205:Ascorbic Acid / Q000627:therapeutic use; D001803:Blood Transfusion; D001810:Blood Volume; D002469:Cell Separation; D002648:Child; D002675:Child, Preschool; D003676:Deferoxamine / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004905:Erythrocyte Aging; D006454:Hemoglobins; D006801:Humans; D006971:Hypersplenism / Q000150:complications; D007501:Iron / Q000097:blood / Q000652:urine; D007502:Iron Chelating Agents / Q000627:therapeutic use; D013156:Splenectomy; D013789:Thalassemia / Q000150:complications / Q000188:drug therapy / Q000628:therapy*
D006454:Hemoglobins; D007502:Iron Chelating Agents; D007501:Iron; D003676:Deferoxamine; D001205:Ascorbic Acid